DE60334316D1 - Frpb proteinmutante und verfahren zur erneuten faltung - Google Patents

Frpb proteinmutante und verfahren zur erneuten faltung

Info

Publication number
DE60334316D1
DE60334316D1 DE60334316T DE60334316T DE60334316D1 DE 60334316 D1 DE60334316 D1 DE 60334316D1 DE 60334316 T DE60334316 T DE 60334316T DE 60334316 T DE60334316 T DE 60334316T DE 60334316 D1 DE60334316 D1 DE 60334316D1
Authority
DE
Germany
Prior art keywords
frpb protein
removal procedure
protein mutant
frpb
mutant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60334316T
Other languages
English (en)
Inventor
Ralph Biemans
Philippe Denoel
Christiane Feron
Carine Goraj
Jeroen Kortekaas
Jan Poolman
Jan Tommassen
Vincent Weynants
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
TECHNOLOGY FOUNDATION STICHTIN
Rijksuniversiteit Utrecht
Original Assignee
GlaxoSmithKline Biologicals SA
TECHNOLOGY FOUNDATION STICHTIN
Rijksuniversiteit Utrecht
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA, TECHNOLOGY FOUNDATION STICHTIN, Rijksuniversiteit Utrecht filed Critical GlaxoSmithKline Biologicals SA
Application granted granted Critical
Publication of DE60334316D1 publication Critical patent/DE60334316D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A61K39/1045—Moraxella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
DE60334316T 2002-08-30 2003-08-28 Frpb proteinmutante und verfahren zur erneuten faltung Expired - Lifetime DE60334316D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0220199.4A GB0220199D0 (en) 2002-08-30 2002-08-30 Mutant protein and refolding method
PCT/EP2003/009634 WO2004020463A2 (en) 2002-08-30 2003-08-28 Mutant protein and refolding method

Publications (1)

Publication Number Publication Date
DE60334316D1 true DE60334316D1 (de) 2010-11-04

Family

ID=9943242

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60334316T Expired - Lifetime DE60334316D1 (de) 2002-08-30 2003-08-28 Frpb proteinmutante und verfahren zur erneuten faltung

Country Status (10)

Country Link
US (1) US20060141563A1 (de)
EP (1) EP1572729B1 (de)
JP (1) JP2006516183A (de)
AT (1) ATE481983T1 (de)
AU (1) AU2003287945A1 (de)
CA (1) CA2495086A1 (de)
DE (1) DE60334316D1 (de)
ES (1) ES2351598T3 (de)
GB (1) GB0220199D0 (de)
WO (1) WO2004020463A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2414667A (en) * 2004-06-03 2005-12-07 Isis Innovation Vaccine compositions of N. meningitidis PorA and FetA antigens
US8329184B2 (en) 2005-06-27 2012-12-11 Glaxosmithkline Biologicals S.A. Process for manufacturing vaccines
DE602007003596D1 (de) * 2006-06-12 2010-01-14 Glaxosmithkline Biolog Sa Impfstoff
CN102333539B (zh) 2008-12-25 2014-06-25 一般财团法人化学及血清疗法研究所 重组禽传染性鼻炎疫苗及其制备方法
ES2759484T3 (es) * 2010-09-10 2020-05-11 Glaxosmithkline Biologicals Sa Meningococo que sobreexpresa NadA y/o NHBA y vesículas de la membrana externa derivadas del mismo
CN103228787B (zh) * 2010-09-28 2017-06-23 阿贝拉生物科学公司 用于分泌性蛋白表达的融合蛋白

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265567B1 (en) * 1995-04-07 2001-07-24 University Of North Carolina At Chapel Hill Isolated FrpB nucleic acid molecule
WO1997023638A1 (fr) * 1995-12-21 1997-07-03 Ajinomoto Co., Inc. Procede pour replier l'activine a humaine
NZ520445A (en) * 2000-01-25 2004-02-27 Univ Queensland Proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA

Also Published As

Publication number Publication date
EP1572729B1 (de) 2010-09-22
WO2004020463A2 (en) 2004-03-11
AU2003287945A1 (en) 2004-03-19
ES2351598T3 (es) 2011-02-08
ATE481983T1 (de) 2010-10-15
AU2003287945A8 (en) 2004-03-19
CA2495086A1 (en) 2004-03-11
WO2004020463A3 (en) 2005-08-18
JP2006516183A (ja) 2006-06-29
GB0220199D0 (en) 2002-10-09
EP1572729A2 (de) 2005-09-14
US20060141563A1 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
EP2444809A3 (de) Verfahren zur Herstellung und zum Screening von Proteasen mit veränderter Spezifizität
DE60326012D1 (de) Verfahren zur Konzentration von Proteinen
DE60309532D1 (de) Verfahren und Vorrichtung zur Komplettierung und Sandrückpacken von Bohrlöchern
DE60335733D1 (de) Verfahren zur solubilisierung von protein
DE60332024D1 (de) Verfahren zur herstellung von soja protein
DE60330376D1 (de) Defructosylierungsverfahren
DE602004023229D1 (de) Mais metallothionen promoter 2 und methoden zur verwendung
BR0308115B1 (pt) artigo de calÇado e mÉtodo de fabricaÇço de artigo de calÇado
DE60309087D1 (de) System und Methode zur Reglung von optischen Verstärkern
ATE495243T1 (de) Verfahren zur herstellung von hochempfindlichen endonukleasen, neuartige zubereitungen von nukleasen und ihre verwendung
SG149000A1 (en) Gag binding proteins
DE60207053D1 (de) Rekombinante gelatineartige proteine zur verwendung als plasmaexpander
FI20020176A (fi) Menetelmä ja reagenssipakkaus geneettisen yhtäläisyyden osoittamiseksi
ATE302844T1 (de) Verfahren zur aufreinigung eines enzyms und hiernach hergestelltes, aufgereinigtes enzym sowie verwendung des enzyms
DE10390418D2 (de) Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen
ATE433441T1 (de) Verfahren und vorrichtung zur herstellung von percarbonsäure
DE60334316D1 (de) Frpb proteinmutante und verfahren zur erneuten faltung
DE60330099D1 (de) Verfahren und Anordnungen zur Herstellung, Feststellung und Übertragung von Identifikatoren
ATE336597T1 (de) Verfahren zur gewinnung von gold
ATE492631T1 (de) Verwendung von mutationen zur verbesserung von aspergillus-phytasen
DE60301283D1 (de) Verfahren zur Bestimmung von Biopolymeren
DE10393421D2 (de) Verfahren zur Anreicherung und zum Nachweis von pathologisch veränderten Prion-Proteinen (PRPSC)
DE60336205D1 (de) Verfahren zur Betriebsmodusnotifizierung.
ATE451457T1 (de) Verfahren zur dipeptidherstellung
DE60236649D1 (de) Methode zur entfernung von allergenen